We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPSA is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1396.7
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
3787.5
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
3466.7
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
3310.6
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
3257.1
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
3190.8
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
3151.3
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
3068.4
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
3020.4
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
2949.9
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
2912.3
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
2899.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
2888.7
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
2859.9
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
2840.2
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
2825.4
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
2724.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2713.9
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2659.0
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
2624.0
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
2616.4
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
2598.8
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
2570.9
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
2560.6
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
2553.3
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
2551.8
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
2544.1
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
2516.9
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
2502.1
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
2479.0
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
2469.6
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
2469.5
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
2419.0
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
2415.8
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
2398.9
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
2385.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
2352.0
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
2341.3
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
2288.4
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
2279.2
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
2267.8
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
2245.0
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
2231.1
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
2227.3
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
2226.0
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
2219.7
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
2205.0
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
2195.0
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
2190.6
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
2174.7
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
2156.9
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
2114.3
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
2091.6
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
2085.1
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
2068.0
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
2057.9
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
2054.0
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
2033.1
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
2003.7
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
2002.1
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
1986.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
1981.6
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
1979.3
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1967.0
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
1958.4
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
1955.5
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
1941.7
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
1931.5
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
1927.7
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
1923.9
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
1922.9
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
1921.8
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
1917.5
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
1917.0
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
1911.2
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
1892.0
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
1887.7
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
1884.5
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
1878.2
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
1847.3
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
1841.4
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1830.7
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
1822.9
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1816.2
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
1808.0
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
1802.6
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
1800.3
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
1794.4
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
1790.9
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
1784.0
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
1781.5
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
1773.2
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
1773.0
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
1768.3
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
1765.3
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
1757.2
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
1740.1
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
1732.7
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
1731.9
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1730.6
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
1717.4
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1708.2
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
1669.1
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
1662.2
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
1661.4
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
1660.6
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
1654.8
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1651.4
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
1651.3
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
1651.0
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
1642.7
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1612.2
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1598.9
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
1598.2
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
1593.4
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1576.2
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
1564.0
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
1563.3
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
1563.0
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1560.8
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
1556.2
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
1553.3
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
1531.0
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
1529.6
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
1521.3
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
1517.5
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
1517.4
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
1513.9
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
1496.3
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
1495.8
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
1492.3
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
1489.5
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
1487.1
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1484.7
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
1483.9
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
1478.9
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
1475.8
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
1474.5
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
1469.7
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
1462.2
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
1459.5
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
1452.8
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
1446.6
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
1445.4
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
1437.5
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1432.2
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
1425.5
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1424.7
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
1419.4
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
1412.2
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
1411.8
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
1408.9
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1403.1
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
1384.9
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
1372.7
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
1371.8
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
1371.1
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
1360.8
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
1355.1
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
1347.0
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
1345.0
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
1337.5
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1329.5
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
1327.1
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
1326.1
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
1325.7
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
1320.6
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
1316.2
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
1315.0
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
1308.2
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1303.2
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1300.0
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
1281.4
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
1261.1
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1252.9
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
1248.6
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
1242.4
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
1228.6
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
1228.4
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
1226.7
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
1226.3
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
1224.3
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
1223.1
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1221.2
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
1211.2
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
1209.1
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
1206.8
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
1206.8
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
1205.2
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
1203.8
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
1185.5
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
1183.8
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
1180.5
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
1166.6
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1164.2
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
1162.6
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
1159.3
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
1158.5
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
1146.7
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1137.0
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
1133.7
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
1130.3
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
1126.0
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
1125.0
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
1124.6
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
1119.3
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
1118.3
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
1116.0
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
1113.1
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
1111.7
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
1107.4
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1104.3
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
1099.4
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
1097.4
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
1095.2
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
1091.1
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
1090.3
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
1089.4
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
1087.9
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
1085.1
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1077.6
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
1072.3
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
1065.1
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
1062.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
1057.7
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
1055.9
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
1054.0
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
1044.1
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
1036.4
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
1035.2
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
1025.0
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
1023.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1009.8
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
1008.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
1007.3
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
1001.5
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
994.0
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
992.5
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
992.2
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
992.2
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
984.9
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
982.1
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
974.7
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
973.9
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
971.6
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
970.5
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
969.8
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
964.6
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
957.6
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
951.9
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
947.6
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
946.1
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
943.9
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
939.1
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
933.5
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
932.9
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
928.9
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
925.7
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
920.3
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
917.9
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
917.3
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
911.0
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
905.2
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
902.5
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
901.7
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
901.1
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
896.0
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
887.9
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
886.6
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
881.4
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
867.6
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
867.0
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
859.1
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
857.4
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
857.0
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
852.0
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
848.9
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
839.6
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
838.7
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
836.2
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
833.1
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
827.5
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
825.4
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
823.7
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
820.6
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
812.7
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
808.9
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
805.1
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
803.0
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
796.8
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
790.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
776.4
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
774.8
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
765.3
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
763.0
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
760.2
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
756.5
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
752.9
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
748.7
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
740.8
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
734.5
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
734.1
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
733.2
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
726.7
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
715.4
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
714.7
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
712.8
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
712.7
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
712.4
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
712.3
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
708.7
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
706.4
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
704.5
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
699.7
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
691.9
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
678.8
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
664.1
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
661.9
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
639.5
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
630.3
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
622.6
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
608.3
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
607.5
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
598.7
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
594.6
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
591.9
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
585.5
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
579.4
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
547.7
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
544.4
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
525.0
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
523.8
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
516.1
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
500.4
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
483.2
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
480.6
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
466.6
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
449.6
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
445.8
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
433.3
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
431.2
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
415.5
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
396.9
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
394.1
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
387.8
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
376.7
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
366.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
356.8
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
355.7
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPSA is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2412.1
Number of samples
81
Samples
Sample
Description
TPM
DO46333
0 years, female, NA, stage:III, dead, 359 days
6784.8
DO46576
0 years, female, NA, stage:III, alive, 133 days
6764.0
DO46384
0 years, female, NA, stage:III, dead, 614 days
5393.1
DO46611
0 years, female, NA, stage:III, dead, 734 days
5072.5
DO46356
0 years, female, NA, stage:III, dead, 911 days
4714.4
DO46518
0 years, female, NA, stage:III, alive, 2960 days
4365.7
DO46402
0 years, female, NA, stage:III, dead, 511 days
4321.5
DO46390
0 years, female, NA, stage:III, dead, 374 days
4252.4
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
4004.2
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
3949.0
DO46586
0 years, female, NA, stage:III, dead, 1019 days
3906.7
DO46331
0 years, female, NA, stage:III, dead, 612 days
3816.0
DO46568
0 years, female, NA, stage:III, dead, 320 days
3815.1
DO46366
0 years, female, NA, stage:III, dead, 2054 days
3771.5
DO46328
0 years, female, NA, stage:III, dead, 972 days
3472.0
DO46352
0 years, female, NA, stage:III, dead, 677 days
3394.0
DO46342
0 years, female, NA, stage:III, dead, 1398 days
3323.5
DO46453
0 years, female, NA, stage:III, dead, 3294 days
3211.0
DO46404
0 years, female, NA, stage:III, dead, 690 days
3135.2
DO46566
0 years, female, NA, stage:III, dead, 673 days
3106.3
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
3063.5
DO46370
0 years, female, NA, stage:III, dead, 1727 days
3037.7
DO46338
0 years, female, NA, stage:III, dead, 596 days
2891.7
DO46591
0 years, female, NA, stage:III, dead, 195 days
2823.2
DO46362
0 years, female, NA, stage:III, dead, 1639 days
2625.2
DO46581
0 years, female, NA, stage:III, dead, 408 days
2618.8
DO46326
0 years, female, NA, stage:III, dead, 701 days
2566.0
DO46388
0 years, female, NA, stage:III, dead, 413 days
2550.2
DO46443
0 years, female, NA, stage:III, dead, 2464 days
2532.3
DO46560
0 years, female, NA, stage:IV, dead, 286 days
2425.7
DO46493
0 years, female, NA, stage:IV, alive, 839 days
2344.7
DO46533
0 years, female, NA, stage:III, alive, 3667 days
2337.4
DO46538
0 years, female, NA, stage:III, dead, 1527 days
2336.2
DO46380
0 years, female, NA, stage:III, dead, 1423 days
2261.4
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
2230.3
DO46392
0 years, female, NA, stage:III, dead, 628 days
2223.4
DO46551
0 years, female, NA, stage:III, dead, 1055 days
2191.0
DO46432
0 years, female, NA, stage:III, alive, 2218 days
2177.4
DO46334
0 years, female, NA, stage:III, dead, 496 days
2158.9
DO46528
0 years, female, NA, stage:III, alive, 6139 days
2139.2
DO46561
0 years, female, NA, stage:III, dead, 195 days
2128.7
DO46350
0 years, female, NA, stage:III, dead, 886 days
2081.6
DO46336
0 years, female, NA, stage:IV, dead, 664 days
2054.2
DO46327
0 years, female, NA, stage:III, dead, 184 days
2031.6
DO46376
0 years, female, NA, stage:III, dead, 1430 days
1943.9
DO46344
0 years, female, NA, stage:III, dead, 642 days
1917.0
DO46396
0 years, female, NA, stage:III, dead, 583 days
1912.4
DO46386
0 years, female, NA, stage:III, dead, 1162 days
1906.9
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
1897.8
DO46508
0 years, female, NA, stage:III, dead, 2101 days
1890.7
DO46378
0 years, female, NA, stage:III, alive, 843 days
1828.8
DO46400
0 years, female, NA, stage:III, dead, 719 days
1825.3
DO46330
0 years, female, NA, stage:III, dead, 684 days
1779.3
DO46325
0 years, female, NA, stage:III, dead, 477 days
1778.1
DO46602
0 years, female, NA, stage:III, dead, 205 days
1751.6
DO46358
0 years, female, NA, stage:III, dead, 423 days
1703.0
DO46546
0 years, female, NA, stage:III, dead, 1889 days
1647.5
DO46382
0 years, female, NA, stage:IV, dead, 311 days
1582.9
DO46463
0 years, female, NA, stage:III, dead, 2451 days
1558.4
DO46364
0 years, female, NA, stage:III, dead, 806 days
1510.3
DO46372
0 years, female, NA, stage:III, dead, 1326 days
1467.0
DO46374
0 years, female, NA, stage:III, dead, 1409 days
1447.2
DO46412
0 years, female, NA, stage:III, dead, 597 days
1421.2
DO46588
0 years, female, NA, stage:III, dead, 438 days
1405.4
DO46597
0 years, female, NA, stage:III, dead, 393 days
1366.2
DO46436
0 years, female, NA, stage:III, alive, 3193 days
1331.6
DO46332
0 years, female, NA, stage:III, dead, 689 days
1303.0
DO46398
0 years, female, NA, stage:III, alive, 437 days
1269.0
DO46340
0 years, female, NA, stage:III, dead, 616 days
1228.2
DO46346
0 years, female, NA, stage:III, dead, 1187 days
1210.6
DO46354
0 years, female, NA, stage:III, dead, 843 days
1196.7
DO46368
0 years, female, NA, stage:III, dead, 2879 days
1186.9
DO46348
0 years, female, NA, stage:IV, dead, 287 days
1097.6
DO46606
0 years, female, NA, stage:III, alive, 804 days
1032.3
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
1031.4
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
1009.4
DO46468
0 years, female, NA, stage:III, alive, 2776 days
1007.0
DO46448
0 years, female, NA, stage:III, dead, 654 days
962.5
DO46571
0 years, female, NA, stage:III, dead, 243 days
956.0
DO46329
0 years, female, NA, stage:III, dead, 1699 days
919.5
DO46408
0 years, female, NA, stage:III, dead, 489 days
696.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.7
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.7
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.6
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.6
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.5
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.5
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.5
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.5
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.5
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.5
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.5
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.5
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.4
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.4
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.4
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.4
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.4
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.4
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.4
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.4
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.4
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.4
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.4
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.3
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.3
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.3
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.3
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.3
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.3
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.3
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.3
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.3
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.3
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.3
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.3
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.2
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.2
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.2
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.2
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.2
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.2
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.2
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.2
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.2
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.2
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.2
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.2
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.2
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.2
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.2
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.2
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.2
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.1
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.1
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.1
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.1
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.1
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.1
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.1
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.1
15524912-685a-47ce-a824-567848_D2
Tumor
0.1
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.1
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.1
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.0
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.0
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.0
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.0
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.1
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.1
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.1
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.1
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.1
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.1
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.1
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.1
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.2
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.2
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-0.2
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.2
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.2
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.3
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.3
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.3
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.4
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.4
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.4
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.5
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.5
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.6
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.6
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.